383 related articles for article (PubMed ID: 16563587)
1. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.
Perrin-Guyomard A; Poul JM; Laurentie M; Sanders P; Fernández AH; Bartholomew M
Regul Toxicol Pharmacol; 2006 Jun; 45(1):66-78. PubMed ID: 16563587
[TBL] [Abstract][Full Text] [Related]
2. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.
Perrin-Guyomard A; Poul JM; Corpet DE; Sanders P; Fernández AH; Bartholomew M
Regul Toxicol Pharmacol; 2005 Jul; 42(2):151-60. PubMed ID: 15963836
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model.
Perrin-Guyomard A; Cottin S; Corpet DE; Boisseau J; Poul JM
Regul Toxicol Pharmacol; 2001 Oct; 34(2):125-36. PubMed ID: 11603955
[TBL] [Abstract][Full Text] [Related]
4. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora.
Carman RJ; Woodburn MA
Regul Toxicol Pharmacol; 2001 Jun; 33(3):276-84. PubMed ID: 11407931
[TBL] [Abstract][Full Text] [Related]
5. Effect of dalbavancin on the normal intestinal microflora.
Nord CE; Rasmanis G; Wahlund E
J Antimicrob Chemother; 2006 Sep; 58(3):627-31. PubMed ID: 16840427
[TBL] [Abstract][Full Text] [Related]
6. Current status of models for testing antibiotic residues.
Corpet DE
Vet Hum Toxicol; 1993; 35 Suppl 1():37-46. PubMed ID: 8236756
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota.
Jeong SH; Song YK; Cho JH
Regul Toxicol Pharmacol; 2009 Apr; 53(3):209-16. PubMed ID: 19545513
[TBL] [Abstract][Full Text] [Related]
8. Effect of ceftaroline on normal human intestinal microflora.
Panagiotidis G; Bäckström T; Asker-Hagelberg C; Jandourek A; Weintraub A; Nord CE
Antimicrob Agents Chemother; 2010 May; 54(5):1811-4. PubMed ID: 20231399
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systemic encephalopathy (PSE).
Esposito S; Barba D; Galante D; Gaeta GB; Laghezza O
Drugs Exp Clin Res; 1987; 13(10):641-6. PubMed ID: 3428128
[TBL] [Abstract][Full Text] [Related]
10. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin at low levels disrupts colonization resistance of human fecal microflora growing in chemostats.
Carman RJ; Simon MA; Fernández H; Miller MA; Bartholomew MJ
Regul Toxicol Pharmacol; 2004 Dec; 40(3):319-26. PubMed ID: 15546686
[TBL] [Abstract][Full Text] [Related]
12. Impact of rufloxacin and ciprofloxacin on the intestinal microflora in a germ-free mice model.
Gismondo MR; Drago L; Lombardi A; Fassina C; Cesana M
Chemotherapy; 1995; 41(4):281-8. PubMed ID: 7555209
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
[TBL] [Abstract][Full Text] [Related]
14. Effects of antimicrobial therapy on the microbial flora of the adenoids.
Brook I
J Antimicrob Chemother; 2003 Jun; 51(6):1331-7. PubMed ID: 12746373
[TBL] [Abstract][Full Text] [Related]
15. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
[TBL] [Abstract][Full Text] [Related]
16. Selected culturable enteric bacterial populations are modified by diet acidification and the growth promotant Tylosin.
Patterson J; Chapman T; Hegedus E; Barchia I; Chin J
Lett Appl Microbiol; 2005; 41(2):119-24. PubMed ID: 16033507
[TBL] [Abstract][Full Text] [Related]
17. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
Scully BE; Jules K; Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of several cytostatic drugs against aerobic and anaerobic intestinal bacteria].
Vetere A; Giuliano M; Pantosti A; Panichi G
Boll Ist Sieroter Milan; 1984; 63(6):505-9. PubMed ID: 6534396
[TBL] [Abstract][Full Text] [Related]
19. Effects of human fecal flora on intestinal morphology and mucosal immunity in human flora-associated piglet.
Che C; Pang X; Hua X; Zhang B; Shen J; Zhu J; Wei H; Sun L; Chen P; Cui L; Zhao L; Yang Q
Scand J Immunol; 2009 Mar; 69(3):223-33. PubMed ID: 19281534
[TBL] [Abstract][Full Text] [Related]
20. Human flora-associated (HFA) animals as a model for studying the role of intestinal flora in human health and disease.
Hirayama K; Itoh K
Curr Issues Intest Microbiol; 2005 Sep; 6(2):69-75. PubMed ID: 16107039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
